High-dose pralidoxime for organophosphorus poisoning.
Goel
Ashish
A
Department of Medicine, All India Institute of Medical Sciences, New Delhi 110029, India. Electronic address: ashgoe@yahoo.com.
Aggarwal
Praveen
P
Department of Medicine, All India Institute of Medical Sciences, New Delhi 110029, India.
Bhoi
Sanjeev
S
Department of Medicine, All India Institute of Medical Sciences, New Delhi 110029, India.
Gupta
Vineet
V
Department of Medicine, All India Institute of Medical Sciences, New Delhi 110029, India.
D001285:Atropine / Q000627:therapeutic use; D002801:Cholinesterase Reactivators / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D062025:Organophosphate Poisoning; D010276:Parasympatholytics / Q000627:therapeutic use; D011220:Pralidoxime Compounds / Q000008:administration & dosage / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic
D002801:Cholinesterase Reactivators; D010276:Parasympatholytics; D011220:Pralidoxime Compounds; D001285:Atropine; C028797:pralidoxime